Physician profile
Marki Swick
NPI 1528562956
$447.44
in general payments reported to CMS, 2019-2025
14 companies · $19.29 in 2025
The $19.29 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.08 · 2023: $259 · 2024: $113 · 2025: $19.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $64.54 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $55.90 | 2023-2024 | Tremfya |
| Leo Pharma INC. | $50.48 | 2023-2025 | Adbry, Anzupgo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.43 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $45.20 | 2022-2023 | Dupixent |
| Dermavant Sciences, INC. | $31.64 | 2023 | Vtama |
| Mylan Institutional INC. | $29.63 | 2023 | Hulio |
| Novartis Pharmaceuticals Corporation | $25.96 | 2023 | |
| Amgen INC. | $22.22 | 2024 | Otezla |
| Ucb, INC. | $16.86 | 2023 | Cimzia |
| Lilly USA, LLC | $16.28 | 2022 | |
| Incyte Corporation | $16.22 | 2023 | Opzelura |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $14.05 | 2024 | |
| Sun Pharmaceutical Industries INC. | $13.03 | 2023 | Ilumya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marki Swick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.